Stonegate Management LLC
Filing Date
Sep 30, 2025
Global Rank
#5,633
/ 7,980
Top Industry
Asset Management
16.4%
3Y Alpha vs SPY
+4.0%
Period ended 9 months ago
Filed Nov 13, 2025 · 7mo
Clone Performance
Nov 2025–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+15.3%
SPY
+13.2%
Annualised alpha
+4.0%
Max drawdown
−9.8%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
42 positions · as of Sep 30, 2025Top Position
33.9%
of portfolio value
Top 5
51.3%
of portfolio value
Top 10
65.8%
of portfolio value
HHI
1,321
Diversified
Sector Breakdown
As of Sep 30, 2025| Sector | % Portfolio | Value |
|---|---|---|
| Unclassified | 39.3% | $38,386,365 |
| Financial Services | 22.9% | $22,376,401 |
| Technology | 9.9% | $9,629,003 |
| Healthcare | 9.0% | $8,818,593 |
| Consumer Cyclical | 4.7% | $4,625,760 |
| Real Estate | 4.2% | $4,085,853 |
| Consumer Defensive | 4.0% | $3,876,622 |
| Energy | 3.2% | $3,123,120 |
| Industrials | 2.9% | $2,789,844 |
6 positions ·
$8,818,593 total
· Healthcare only
· as of Sep 30, 2025
All sectors
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| ABBV |
AbbVie Inc.
Healthcare
|
First | 17,993 | $4,166,099 | 47.24% | |
| CI |
Cigna Group
Healthcare
|
First | 8,150 | $2,349,237 | 26.64% | |
| MRK |
Merck & Co., Inc.
Healthcare
|
First | 10,245 | $859,862 | 9.75% | |
| ELV |
Elevance Health, Inc.
Healthcare
|
First | 1,910 | $617,159 | 7.00% | |
| ABT |
Abbott Laboratories
Healthcare
|
First | 3,400 | $455,396 | 5.16% | |
| JNJ |
Johnson & Johnson
Healthcare
|
First | 2,000 | $370,840 | 4.21% |